Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Mesa Laboratories's share price for the quarter that ended in Dec. 2023 was €94.5. Mesa Laboratories's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 5.4 Mil. Therefore, Mesa Laboratories's market cap for the quarter that ended in Dec. 2023 was €509.7 Mil.
Mesa Laboratories's quarterly market cap
declined
from Jun. 2023 (€656.9 Mil) to Sep. 2023 (€525.7 Mil) and
declined
from Sep. 2023 (€525.7 Mil) to Dec. 2023 (€509.7 Mil).
Mesa Laboratories's annual market cap
increased
from Mar. 2021 (€1,059.0 Mil) to Mar. 2022 (€1,190.0 Mil) but then
declined
from Mar. 2022 (€1,190.0 Mil) to Mar. 2023 (€832.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mesa Laboratories's Enterprise Value for Today is €653.4 Mil.
Mesa Laboratories Market Cap Historical Data
The historical data trend for Mesa Laboratories's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mesa Laboratories's Market Cap
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories's Market Cap Distribution in the Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's Market Cap distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's Market Cap falls into.
Mesa Laboratories Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Mesa Laboratories's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (FRA:MLI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Mesa Laboratories Market Cap Related Terms
Thank you for viewing the detailed overview of Mesa Laboratories's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:MLI has been successfully added to your 